Gut Microbiota and Mitochondrial Dysfunction in Autism: Clinical Correlations and Future Directions

Jan 23, 2026Molecular neurobiology

Gut Bacteria and Mitochondrial Problems in Autism: Clinical Links and Future Research

AI simplified

Gut-Brain Axis on OpenScience ↗PubMed ↗DOI ↗

Abstract

Autism spectrum disorder (ASD) is associated with significant changes in gut microbiota, including a decrease in beneficial microbes and an increase in pathogenic taxa.

ASD patients exhibit alterations in gut microbiota composition that may influence neuroactive metabolite production.
These microbial changes are linked to mitochondrial dysfunction, affecting immune modulation and neurotransmission.
Microbial metabolites are identified as regulators of mitochondrial activity through pathways involving the vagus nerve and immune signaling.
Different mitochondrial signaling pathways, including AMPK, mTOR, and NF-κB, may be inhibited in ASD.
Future research is needed to address gaps in understanding the gut-brain axis and its impact on ASD for personalized therapies.

AI simplified

Autism spectrum disorder (ASD) is a multifactorial, neuro-psychiatric, and neurodevelopmental illness possessing impaired social, behavioral, and communicative presentations. Research suggested the important role of the gut-brain axis in ASD, especially related to gut dysbiosis and mitochondrial dysfunction. This review comprehensively summarizes the existing evidence of the association between gut microbiota, microbial metabolites, and mitochondrial dysfunction in ASD, comprising of clinical, experimental, and epidemiological data over the last decade. The focus was on the research that clarifies the gut-mitochondria crosstalk and role in ASD pathophysiology. ASD patients demonstrate a substantial shift in the variety of gut microbiota, such as a decrease in the number of beneficial microbes and the growth of pathogenic taxa. These changes affect the biosynthesis of major neuroactive metabolites executing immune modulation and neurotransmission. The review detects the microbial metabolites that regulate mitochondrial activity through mechanisms like vagus nerve, intestinal hormones, and immune signaling. The different mitochondrial signaling pathways were inhibited including AMPK, mTOR, and NF-κB. Preventive interventions that concentrate on modulation of the microbiome and mitochondria may present a prospective line of therapy. Nevertheless, uncovered gaps should be mentioned in future research, multi-omics studies, longitudinal studies, and the protocol to understand the components of gut-brain axis in ASD to develop personalized therapy.

Full Text

Full text is available at the source.

View full text (PDF) ↗View full text (HTML) ↗

Gut Microbiota and Mitochondrial Dysfunction in Autism: Clinical Correlations and Future Directions

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the gut-brain axis brief